Pyrafat

Medicinal product

(Invented) name

Pyrafat

Active substance (s)

Pirazinamidas

Strength

500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J04AK01, Pyrazinamide

Marketing authorisation holder

Esteve Pharmaceuticals GmbH, Vokietija

Date of authorisation

1997-10-01

Date of renewal

2014-01-31

Documents

3504 Pakuotės lapelis 2022 01 28.docx

3504 Pyrafat 500mg tab RPP 2022 01 28.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Pirazinamidas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
11851	1644	1001644	tablečių talpyklė	N100		Receptinis	LT/1/97/3504/001	Tiekiama	-	-	No	-	-
11852	16285	1016285	tablečių talpyklė	N1000		Receptinis	LT/1/97/3504/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-01-31	Perregistruotas
1997-10-01	Registruotas